Biochemistry and biomedical chemistry
PROTACs, targeted protein degradation
PROTACs are heterobifunctional molecules that redirect cellular protein-quality-control machinery to degrade a selected target.
IntuitionIntuition: the central idea
PROTACs are heterobifunctional molecules that redirect cellular protein-quality-control machinery to degrade a selected target.
SchoolSchool level: key concepts and a first application
Definition: Core concept
One end binds a protein of interest and the other an E3 ubiquitin ligase. Productive ternary-complex formation can trigger ubiquitination and proteasomal degradation; the degrader may act catalytically.
A PROTAC usually has a target ligand, linker and E3-recruiting ligand. Linker length, exit-vector orientation and ternary-complex cooperativity are central design variables.
| Term | Interpretation |
|---|---|
| POI | Protein of interest selected for degradation. |
| E3 ligase | Enzyme recruiting ubiquitin-transfer machinery to substrates. |
| Hook effect | Reduced efficacy at excess degrader when binary complexes dominate. |
Example: Apply the idea
Why may increasing PROTAC concentration eventually reduce degradation in some systems?
Solution
At high concentration, separate binary target–PROTAC and E3–PROTAC complexes can dominate over productive ternary complexes, producing a hook effect.
UndergraduateUniversity level: quantitative description
A useful degrader must form a ternary complex, catalyse ubiquitination efficiently enough for turnover, and avoid hook-effect losses at elevated concentration.
AdvancedAdvanced: assumptions and mechanistic detail
The mechanism is event-driven rather than occupancy-driven: one degrader molecule can mediate multiple turnover cycles. Molecular glues, molecular degraders and PROTACs form a related design family.
ResearchResearch frontier: open questions and current practice
References
- Protacs: chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradation · Kathleen M. Sakamoto; Kyung Bo Kim; Akiko Kumagai; Frank Mercurio; Craig M. Crews; Raymond J. Deshaies, 2001
- PROTAC targeted protein degraders: the past is prologue · Mátyás Békés; Daren R. Langley; Craig M. Crews, 2022